Preoperative chemotherapy for operable breast cancer.

[1]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. D. Hoff.  Phase I trials of dexrazoxane and other potential applications for the agent. , 1998 .

[3]  Mamounas Ep.  Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies. , 1998 .

[4]  B Fisher,et al.  Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. , 1997, Journal of the National Cancer Institute.

[5]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Mamounas Ep.  NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel , 1997 .

[7]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[8]  Mike Clarke,et al.  EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS , 1995 .

[9]  C. Redmond,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.

[10]  T. Powles,et al.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Mamounas,et al.  Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Y. Bignon,et al.  Neoadjuvant chemotherapy in 126 operable breast cancers. , 1992, European journal of cancer.

[13]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[14]  L. Mauriac,et al.  Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.

[16]  C. Jacquillat,et al.  Results of neoadjuvant chemotherapy and radiation therapy in the breast‐conserving treatment of 250 patients with all stages of infiltrative breast cancer , 1990, Cancer.

[17]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[18]  H. Seydel,et al.  Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Butler,et al.  Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer , 1983, Journal of surgical oncology.

[20]  N Gunduz,et al.  Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.

[21]  G. Lesnick,et al.  Chemotherapy before and after mastectomy in stage III breast cancer. , 1982, Archives of surgery.

[22]  G. Rosen,et al.  Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy , 1982, Cancer.

[23]  B. Fisher.  Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. , 1980, Cancer research.

[24]  N Gunduz,et al.  Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.

[25]  Goldie Jh,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .

[26]  H. Skipper,et al.  Kinetics of mammary tumor cell growth and implications for therapy , 1971, Cancer.

[27]  B. Asselain,et al.  Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.

[28]  M. Baum,et al.  Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. , 1993, European journal of cancer.

[29]  F. Spyratos,et al.  Preoperative chemotherapy of operable breast cancer (stage IIIA). Prognostic factors of distant recurrence , 1993 .

[30]  Earlybreastcancertrialistscol,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[31]  H. Wilson,et al.  Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx , 1983, Cancer.